GlassScriptPhysician profile
Hope Ashley Jacoby
NPI 1336523455
$18,005.79
in general payments reported to CMS, 2019-2025
30 companies · $298 in 2025
The $298 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,589 · 2021: $1,195 · 2022: $2,999 · 2023: $77.73 · 2024: $171 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $9,581.20 | 2019 | |
| Arthrex, INC. | $2,572.80 | 2020-2022 | |
| Pylant Medical | $1,497.68 | 2019-2022 | |
| Smith+Nephew, INC. | $1,008.45 | 2019-2025 | Capture, Bone Anchors With Arthroscopic Delivery System, Large Qwix |
| Stryker Corporation | $652.81 | 2019-2025 | Augment Injectable, Ortholoc 3di Crosscheck |
| Hartmann USA, INC. | $392.11 | 2020-2025 | Zetuvit Plus 10x10 P10 |
| Horizon Therapeutics Plc | $359.32 | 2019-2021 | |
| Wright Medical Technology, INC. | $272.63 | 2019-2020 | |
| Crossroads Extremity Systems, LLC | $235.89 | 2019 | |
| Melinta Therapeutics, LLC | $221.66 | 2019-2022 | |
| Paragon 28, INC. | $193.33 | 2021 | |
| Normatec Industries, LP | $132.55 | 2019-2020 | |
| Organogenesis INC. | $125.45 | 2021-2025 | Affinity, Puraply |
| Celularity INC. | $111.17 | 2021 | |
| Embody, INC. | $109.25 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $89.49 | 2021 | |
| Paratek Pharmaceuticals, INC. | $67.90 | 2021-2025 | Nuzyra |
| Depuy Synthes Sales INC. | $66.40 | 2019-2020 | |
| Abbvie INC. | $58.30 | 2021-2022 | |
| Nabriva Therapeutics, Plc | $49.12 | 2021-2022 | |
| Averitas Pharma INC. | $35.47 | 2025 | Qutenza |
| Kci USA, INC. | $30.72 | 2019-2020 | |
| Convatec INC. | $29.18 | 2022 | |
| Kerecis Limited | $22.27 | 2021 | |
| Nevro Corp. | $18.20 | 2022 | |
| Orthofix Medical, INC. | $17.11 | 2021 | |
| Tactile Systems Technology INC | $16.07 | 2021 | |
| Access Pro Medical, LLC | $14.27 | 2023 | Matriderm |
| Anika Therapeutics, INC. | $13.76 | 2021 | |
| Merck Sharp & Dohme LLC | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hope Jacoby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.